Scientists test new Melt-in-Your-Mouth migraine drug form
NCT ID NCT07445464
Summary
This early-stage study aims to understand how the body absorbs and processes two new fast-dissolving tablet versions of a migraine drug called flunarizine. It will compare these new tablets to the standard pill already available in some countries. The study involves 12 healthy adults who will each try all five different tablet types in a specific order to see how they compare.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHARMACOKINETIC ANALYSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.